Boeing's Fixed-Price Deal Losses Sharpen Defense Overhang

What happened

The WSJ article indicates that losses from Boeing's fixed-price defense contracts are becoming more transparent, with additional charges likely disclosed in Q3 2026. This development aligns with previously flagged risks, including the $280 million VC-25B charge in Q2 2026 and the ongoing threat of 777X reach-forward losses. The cumulative impact further pressures Boeing's already weak profitability, as the defense segment continues to underperform while commercial recovery remains dependent on FAA-gated milestones. Management's optimistic production guidance should be viewed skeptically, as cash flow remains vulnerable to legacy program overruns. With the stock trading around 30x EV/EBITDA, there is little margin for error if these losses escalate.

Implication

Investors should monitor upcoming earnings calls and disclosures for any additional charges on programs like VC-25B, KC-46A, or 777X, as these could further erode cash flow and delay deleveraging. The commercial recovery story remains intact but is now even more dependent on achieving production rate increases and certifications without setbacks. Given the full valuation, any disappointment in either commercial execution or defense loss containment could trigger a sharp de-rating. A more attractive entry point may emerge if the stock approaches the previously identified $210 level, which offers a better risk-reward. Until then, maintaining a wait-and-see approach with disciplined monitoring is prudent.

Thesis delta

The thesis shifts from a balanced WAIT to a more cautious stance due to heightened clarity on fixed-price deal losses, which could consume recovery cash. While commercial recovery remains the primary long-term driver, defense losses now present a more concrete near-term drag, reducing the margin for error. Conviction in the current rating edges down, but the rating remains WAIT pending evidence of loss containment.